world
health
organ
recent
declar
ongo
outbreak
caus
novel
coronaviru
pandem
current
lack
knowledg
antibodi
respons
elicit
infect
one
major
immunolog
question
concern
antigen
differ
sarscov
address
question
use
plasma
patient
infect
sarscov
plasma
obtain
infect
immun
mice
result
show
crossreact
antibodi
bind
spike
protein
common
crossneutr
live
virus
rare
indic
presenc
nonneutr
antibodi
respons
conserv
epitop
spike
whether
nonneutr
antibodi
respons
lead
antibodydepend
diseas
enhanc
need
address
futur
overal
studi
address
fundament
question
regard
antigen
differ
sarscov
also
import
implic
vaccin
develop
emerg
spread
novel
coronaviru
caus
sever
respiratori
diseas
led
pandem
major
impact
global
health
economi
societ
behavior
coronavirida
studi
group
intern
committe
taxonomi
poon
peiri
zhu
et
al
march
confirm
case
report
close
death
phylogenet
analysi
demonstr
sar
cov
coronaviru
also
caus
global
outbreak
close
relat
phylogenet
genom
nucleotid
sequenc
ident
around
wu
et
al
zhou
et
al
moreov
shown
virus
use
angiotensinconvert
enzym
receptor
cell
entri
infect
letko
et
al
li
et
al
spike
glycoprotein
surfac
coronavirus
essenti
viru
entri
bind
receptor
viral
fusion
host
cell
protein
form
homotrim
protom
compos
two
subunit
figur
bind
receptorbind
domain
rbd
subunit
receptor
trigger
conform
chang
protein
subsequ
initi
membran
fusion
event
host
cell
rbd
also
primari
target
antibodi
respons
humor
immun
believ
major
protect
antigen
chen
et
al
prefus
structur
protein
recent
determin
cryoem
wrapp
et
al
reveal
overal
structur
similar
sarscov
howev
monoclon
antibodi
test
date
target
rbd
sarscov
fail
bind
rbd
tian
et
al
wrapp
et
al
suggest
antigen
two
polyclon
human
sera
patient
evalu
antibodi
respons
elicit
infect
determin
whether
crossreact
antibodi
respons
sarscov
gener
studi
examin
antibodi
respons
patient
hong
kong
infect
seven
sarscov
mice
infect
immun
sarscov
also
use
investig
crossreact
antibodi
respons
sar
sarscov
fifteen
heparin
anticoagul
plasma
sampl
day
postsymptom
onset
infect
patient
analyz
tabl
bind
plasma
ectodomain
rbd
sarscov
see
method
measur
elisa
figur
figur
plasma
sampl
healthi
donor
collect
hong
kong
red
cross
serv
control
compar
plasma
healthi
donor
plasma
patient
day
postsymptom
onward
react
strongli
elisa
bind
assay
ectodomain
pvalu
tail
ttest
rbd
pvalu
twotail
ttest
interestingli
plasma
patient
could
also
crossreact
although
less
strongli
sarscov
ectodomain
pvalu
twotail
ttest
sarscov
rbd
pvalu
twotail
ttest
figur
nevertheless
five
sampl
patient
convinc
antibodi
bind
respons
sarscov
rbd
plasma
react
weakli
sarscov
rbd
figur
result
indic
crossreact
antibodi
respons
protein
infect
mostli
target
nonrbd
region
consist
observ
reactiv
plasma
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
infect
patient
could
detect
subunit
pvalu
twotail
ttest
figur
also
analyz
seven
heparin
anticoagul
convalesc
month
post
infect
plasma
sampl
sarscov
infect
patient
similar
observ
plasma
sampl
patient
crossreact
bind
could
detect
figur
compar
plasma
healthi
donor
infect
patient
signific
crossreact
bind
spike
valu
twotail
ttest
rbd
pvalu
twotail
ttest
subunit
valu
twotail
ttest
result
show
crossreact
bind
common
sarscov
infect
direct
next
test
neutral
activ
plasma
sampl
infect
patient
except
four
plasma
sampl
came
patient
less
day
postsymptom
onset
concomitantli
low
reactiv
ectodomain
rbd
plasma
sampl
could
neutral
viru
titer
rang
figur
tabl
howev
one
plasma
sampl
could
crossneutr
sarscov
low
neutral
activ
fact
crossneutr
plasma
sampl
strongest
reactiv
bind
sarscov
ectodomain
among
patient
sampl
although
bind
activ
sarscov
rbd
particularli
strong
tabl
similarli
five
seven
plasma
sampl
sarscovconvalesc
patient
could
neutral
sarscov
titer
rang
none
neutral
figur
result
show
although
crossreact
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
bind
common
plasma
sarscov
infect
patient
crossneutr
activ
rare
investig
crossreact
antibodi
respons
sarscov
analyz
antibodi
respons
plasma
collect
mice
infect
immun
sarscov
n
per
experiment
control
group
plasma
mice
mock
immun
genet
distant
betacoronaviru
coronaviru
pb
adjuv
use
neg
control
figur
compar
control
plasma
mice
immun
viru
react
strongli
autolog
ectodomain
pvalu
twotail
ttest
figur
rbd
pvalu
twotail
ttest
figur
similarli
plasma
mice
immun
sarscov
viru
react
strongli
autolog
ectodomain
pvalu
twotail
ttest
figur
rbd
pvalu
twotail
ttest
figur
addit
plasma
mice
immun
sarscov
ectodomain
could
react
autolog
rbd
pvalu
twotail
test
figur
howev
plasma
mice
infect
sarscov
viru
could
react
autolog
ectodomain
pvalu
twotail
ttest
figur
rbd
pvalu
twotail
ttest
figur
reactiv
plasma
mice
infect
viru
autolog
ectodomain
rbd
could
observ
assay
pvalu
twotail
ttest
figur
b
unlik
sarscov
viru
replic
wildtyp
mice
yang
et
al
recent
shown
abl
replic
human
transgen
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
interestingli
observ
crossreact
plasma
immun
mice
sarscov
ectodomain
pvalu
twotail
ttest
figur
less
sarscov
rbd
pvalu
twotail
ttest
figur
well
plasma
sarscovinfect
mice
ectodomain
valu
twotail
ttest
figur
conclus
crossreact
antibodi
mostli
target
nonrbd
region
support
stronger
reactiv
antibodi
respons
immun
sarscov
ectodomain
rbd
plasma
sarscovinfect
mice
react
rbd
pvalu
twotail
ttest
figur
despit
presenc
work
show
antibodi
respons
infect
patient
cohort
gener
protein
rbd
major
patient
furthermor
crossreact
sarscov
detect
plasma
sampl
well
mice
studi
crossreact
antibodi
respons
mostli
target
rbd
region
consist
higher
sequenc
conserv
found
subunit
sarscov
aminoacid
sequenc
ident
compar
rbd
aminoacid
sequenc
ident
nonetheless
patient
abl
produc
crossreact
antibodi
respons
sarscov
rbd
consist
find
human
antibodi
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
crossreact
antibodi
bind
respons
sarscov
protein
appear
rel
common
cohort
crossneutr
respons
rare
one
patient
abl
gener
neutral
respons
sarscov
virus
reactiv
respons
weak
therefor
possibl
subset
crossreact
bind
epitop
bona
fide
neutral
epitop
notion
also
support
recent
studi
show
crossreact
antibodi
could
neutral
despit
strong
bind
yuan
et
al
futur
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
spike
protein
design
knockout
furin
cleavag
site
novel
addit
coronaviru
compar
relat
sequenc
bat
pangolin
wong
et
al
spike
ectodomain
construct
fuse
n
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
bao
l
deng
w
huang
b
gao
h
liu
j
ren
l
wei
q
yu
p
xu
qi
f
et
al
pathogen
transgen
mice
biorxiv
bootz
karbach
spindler
j
kropff
b
reuter
n
sticht
h
winkler
th
britt
wj
mach
protect
capac
neutral
nonneutr
ccbi
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
